Wildomar, CA, United States of America

Judith Gail Deal

USPTO Granted Patents = 21 

 

 

Average Co-Inventor Count = 6.9

ph-index = 6

Forward Citations = 174(Granted Patents)


Location History:

  • Temecula, CA (US) (1998 - 2002)
  • Wildomar, CA (US) (2003 - 2016)
  • San Diego, CA (US) (2014 - 2022)

Company Filing History:


Years Active: 1998-2025

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: Judith Gail Deal: A Pioneering Innovator in Cancer Treatment

Introduction

Judith Gail Deal, based in Wildomar, California, is an esteemed inventor with a remarkable portfolio of 20 patents. Her innovative work primarily focuses on the development of solutions for abnormal cell growth, including cancer. Judith's contributions to the field of pharmaceutical science are significant, showcasing her expertise and dedication to improving patient outcomes through cutting-edge research.

Latest Patents

Among Judith's notable patents is a groundbreaking invention related to cyclin-dependent kinase inhibitors. This patent pertains to compounds of Formula (I) or their pharmaceutically acceptable salts, which have been designed for pharmaceutical compositions aimed at treating abnormal cell growth. The compounds and their applications are crucial in the fight against cancer, providing new avenues for therapeutic interventions that could significantly enhance patient care.

Career Highlights

Judith's career is marked by her tenure at leading pharmaceutical companies, including Agouron Pharmaceuticals, Inc. and Pfizer Corporation. Throughout her time in these organizations, she has played a vital role in developing innovative solutions that address pressing healthcare challenges. Her experience in large-scale pharmaceutical companies reflects her capacity to collaborate on impactful projects within the industry.

Collaborations

Collaboration has been a key aspect of Judith's success. Notably, she has worked alongside esteemed colleagues such as Cynthia Louise Palmer and Robert Steven Kania. These partnerships have allowed her to combine expertise and drive innovation in the field of cancer treatment, leading to the successful development of her patented technologies.

Conclusion

Judith Gail Deal stands out as a formidable inventor whose work in cyclin-dependent kinase inhibitors exemplifies the potential of innovative solutions in the medical field. Her contributions not only advance scientific understanding but also offer hope for effective therapies against cancer. With a solid track record of patents and collaborations, Judith continues to be a pivotal figure in the ongoing battle for improved cancer treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…